Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

DES daughter

(… DAH-ter)
A female who was exposed before birth to a synthetic form of the hormone estrogen called diethylstilbestrol (DES) because their mother took DES while pregnant with them. DES was prescribed for some pregnant women between about 1940 and 1971 because it was thought to prevent miscarriage, premature labor, and other complications related to pregnancy. It was stopped in 1971 due to medical problems that were seen in the children of women who took it. DES daughters were found to have an increased risk of precancerous lesions in the cervix and clear cell adenocarcinoma of the cervix or vagina. DES daughters may also have an increased risk of breast cancer, pancreatic cancer or other pancreatic disorders, cardiovascular disease, and depression. Other health problems that may have affected DES daughters include early menopause, fertility and pregnancy problems, and structural changes in the female reproductive tract.
More Information
Search NCI's Dictionary of Cancer Terms